Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma
Authors
Keywords
-
Journal
Oncology Letters
Volume 6, Issue 5, Pages 1234-1240
Publisher
Spandidos Publications
Online
2013-08-29
DOI
10.3892/ol.2013.1552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concurrent Weekly Docetaxel Chemotherapy in Combination with Radiotherapy for Stage III and IVA-B Nasopharyngeal Carcinoma
- (2012) Wei-Hong Wei et al. Asian Pacific Journal of Cancer Prevention
- The Akt/mammalian target of rapamycin pathway is activated and associated with adverse prognosis in soft tissue leiomyosarcomas
- (2011) Nokitaka Setsu et al. CANCER
- Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial–mesenchymal transition
- (2011) T Li et al. CANCER GENE THERAPY
- Ionizing Radiation Promotes Migration and Invasion of Cancer Cells Through Transforming Growth Factor-Beta–Mediated Epithelial–Mesenchymal Transition
- (2011) Yong-Chun Zhou et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
- (2011) A Fernandez-L et al. ONCOGENE
- Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients
- (2011) Monique M. Nijkamp et al. RADIOTHERAPY AND ONCOLOGY
- E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
- (2011) Jan Theys et al. RADIOTHERAPY AND ONCOLOGY
- Activation of AKT is associated with metastasis of nasopharyngeal carcinoma
- (2011) Ying Liu et al. TUMOR BIOLOGY
- The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
- (2010) Carlos A. Castaneda et al. CANCER AND METASTASIS REVIEWS
- GSK690693 Delays Tumor Onset and Progression in Genetically Defined Mouse Models Expressing Activated Akt
- (2010) D. A. Altomare et al. CLINICAL CANCER RESEARCH
- Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program
- (2010) Hernan Carol et al. PEDIATRIC BLOOD & CANCER
- Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
- (2009) M. Santisteban et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
- (2009) Hui-Fang Li et al. Radiation Oncology
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
- (2008) N. Rhodes et al. CANCER RESEARCH
- Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase
- (2008) Dirk A. Heerding et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer
- (2008) Johan Bussink et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started